Reviewing Surgery Partners (SGRY) & The Competition
Surgery Partners (NASDAQ: SGRY) is one of 15 public companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it compare to its competitors? We will compare Surgery Partners to related companies based on the strength of its analyst recommendations, risk, profitability, earnings, valuation, dividends and institutional ownership.
This table compares Surgery Partners and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Surgery Partners Competitors||3.52%||3.52%||4.31%|
94.2% of Surgery Partners shares are held by institutional investors. Comparatively, 69.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 7.6% of Surgery Partners shares are held by insiders. Comparatively, 10.4% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
This is a breakdown of current recommendations for Surgery Partners and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Surgery Partners Competitors||57||326||509||9||2.52|
Surgery Partners currently has a consensus price target of $18.00, indicating a potential upside of 109.30%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 21.23%. Given Surgery Partners’ higher possible upside, research analysts plainly believe Surgery Partners is more favorable than its competitors.
Earnings & Valuation
This table compares Surgery Partners and its competitors revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Surgery Partners||$1.15 billion||$9.45 million||-95.56|
|Surgery Partners Competitors||$1.06 billion||-$22.56 million||690.45|
Surgery Partners has higher revenue and earnings than its competitors. Surgery Partners is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Surgery Partners competitors beat Surgery Partners on 8 of the 12 factors compared.
About Surgery Partners
Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company’s surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company’s Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company’s physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company’s Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.